By surpassing 500 crores nett in India and 1000 crores gross internationally, Pathaan revolutionised what it means to be a box office success.
All estimates and projections about Shah Rukh Khan’s Pathaan’s unprecedented box office performance around the world were proven wrong. It broke too many prior records to list as it exceeded 500 crores nett in India and 1000 crores gross globally. The most recent information we have is regarding a unique feat performed by the SRK monster.
The film, directed by Siddharth Anand, served as the official launchpad for YRF’s Spy Universe. Shah Rukh returned to the big screen for the first time in four long years with this film. Fans got to witness SRK in a never-before-seen role, and he truly wrecked havoc at the box office, earning him the title of “King of Bollywood.” It was worth the wait.
Returning to a recent accomplishment, Pathaan has finished its 100-day run in theatres. It’s true what you just read! The action spectacular is still playing in theatres, making it the fourth Indian film to accomplish this record since the post-pandemic era began. It has joined the league of Kantara, RRR, KGF Chapter 2, and other films that have shown in theatres for 100 days or more.
Pathaan will debut in Bangladesh after 1971 as the first Hindi movie to do so. In Bangladesh, it is scheduled to be released on May 12.
Nelson D’Souza, Vice President, International Distribution said, “Cinema has always been a unifying force between nations, races and cultures. It transcends borders, galvanises people and plays a significant hand in bringing people together.” He also added, “Pathaan becomes the first Hindi film to release in Bangladesh post-1971 and we are thankful to the authorities for their decision. We have learnt over the years that Shah Rukh Khan has a tremendous fan following in Bangladesh and we feel Pathaan, our latest offering from YRF’s Spy Universe, is the perfect first film of SRK & Hindi cinema to release in the country and represent Indian culture and cinema in its full glory.”
Home
